Evidence map›Paper›PMID 25917089›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.

Francesca Wanda Rossi, Filomena Napolitano, Ada Pesapane, Massimo Mascolo, Stefania Staibano, Marco Matucci-Cerinic, Serena Guiducci, Pia Ragno, Gaetano di Spigna, Loredana Postiglione and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Formyl Peptide Receptor-2-Suppressed Autophagy Promotes the Migration and Invasion of Human Glioblastoma Cells Through PI3K/Akt Signaling.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  3. Review
  4. Article
  5. TheFrontiers in immunology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Therapeutic potential of WKYMVm in diseases.Frontiers in pharmacology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Francesca Wanda RossiDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
Filomena NapolitanoDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
Ada PesapaneDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
Massimo MascoloDepartment of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy;
Stefania StaibanoDepartment of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy;
Marco Matucci-CerinicDepartment of Biomedicine, University of Florence, 50121 Florence, Italy; and.
Serena GuiducciDepartment of Biomedicine, University of Florence, 50121 Florence, Italy; and.
Pia RagnoDepartment of Chemistry and Biology, University of Salerno, 84084 Salerno, Italy.
Gaetano di SpignaDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
Loredana PostiglioneDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
Gianni MaroneDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
Nunzia MontuoriDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy; nmontuor@unina.it.
Amato de PaulisDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research, University of Naples Federico II, 80131 Naples, Italy;
University of Naples Federico II · ITFederico II University Hospital · ITUniversity of Florence · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic sclerosis (SSc) is characterized by chronic inflammation and fibrosis. N-Formyl peptide (fMLF) receptors (FPRs) are chemotactic receptors involved in inflammation. Three FPRs have been identified: FPR1, FPR2, and FPR3. We have examined, by RT-PCR, Western blot and immunohistochemistry, FPRs expression in skin fibroblasts from 10 normal subjects and 10 SSc patients, showing increased expression in SSc fibroblasts. Several functions of FPRs occur through the interaction with a region of the urokinase-type plasminogen activator receptor (uPAR88-92), able to interact with FPRs and to mediate urokinase (uPA) or fMLF-dependent cell migration. Soluble uPAR84-95 peptide can act as a direct ligand of FPRs. Furthermore, uPA or its aminoterminal fragment (ATF) can promote the exposure of the uPAR88-92 region. The WKYMVm peptide is a FPRs pan-agonist. We investigated the functional effects of these agonists on normal and SSc fibroblasts. ATF, uPAR84-95, and WKYMVm regulated adhesion, migration, and proliferation of normal fibroblasts. Despite FPR overexpression, the response of SSc fibroblasts to the same agonists was greatly reduced, except for the proliferative response to ATF. SSc fibroblasts showed increased α-smooth muscle actin expression and improved capability to induce wound closure. Indeed, they overexpressed a cleaved uPAR form, exposing the uPAR88-92 region, and vitronectin, both involved in fibrosis and in the fibroblast-to-myofibroblast transition. FPR stimulation promoted α-smooth muscle actin expression in normal fibroblasts as well as motility, matrix deposition, αvβ5 integrin expression, and radical oxygen species generation in normal and SSc fibroblasts. This study provides evidence that FPRs may play a role in fibrosis and in the fibroblast-to-myofibroblast transition.

Indexed as

ActinsAdultAgedCell AdhesionCell DifferentiationCell MovementCell ProliferationCells, CulturedFemaleFibrosisHumansInflammationMaleMiddle AgedMyofibroblastsOligopeptidesActinsFPR1 protein, humanFPR2 protein, humanFPR3 protein, humanintegrin alphaVbeta5OligopeptidesPeptide FragmentsReactive Oxygen SpeciesReceptors, Formyl PeptideReceptors, LipoxinReceptors, Urokinase Plasminogen ActivatorReceptors, VitronectinTrp-Lys-Tyr-Met-Val-MetUrokinase-Type Plasminogen ActivatorVitronectin

Identifiers

PMID25917089
OpenAlexW1780887012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.